Prognostic factors and selection criteria in the retreatment of head and neck cancers
Authors:
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 88, 85-90
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiationThe Laryngoscope, 2010
- Prognostic Factors for Survival After Salvage Reirradiation of Head and Neck CancerJournal of Clinical Oncology, 2009
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911Journal of Clinical Oncology, 2007
- Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neckHead & Neck, 2007
- Oncologic effectiveness of selective neck dissection in the N0 irradiated neckHead & Neck, 2005
- Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgeryHead & Neck, 2003
- Prognostic implications of perineural spread in squamous carcinomas of the head and neckThe Laryngoscope, 1986
- The significance of “positive” margins in surgically resected epidermoid carcinomasHead & Neck Surgery, 1978